<DOC>
	<DOCNO>NCT02355210</DOCNO>
	<brief_summary>This study evaluate effect dietary supplement improve gut health . The participant take one six dietary treatment three week , gut bacteria gut intestinal barrier assess determine dietary treatment beneficially change marker gut health .</brief_summary>
	<brief_title>Use Novel Synbiotic Change Human Gut Bacteria Improve Health Obese Adults</brief_title>
	<detailed_description>In study , intend test ecological therapeutic functionality synbiotic combination Bifidobacterium adolescentis strain prebiotic galactooligosaccharide ( GOS ) human clinical trial . The synbiotic combination select base novel vivo selection ; specifically , strain ( BD1 ) human autochthonous gut organism enrich individual GOS . Our experiment test efficacy synbiotic compare conventional synbiotic . We hypothesize rationally select synbiotic improve intestinal barrier function obese adult subject , thereby prevent endotoxemia metabolic inflammation , physiologically relevant function increase obese individual . Our objective : ( 1 ) compare ability test control synbiotic preparation alter gut microbiota obese individual ; ( 2 ) test GOS support colonization metabolic activity test control strain human gut ; ( 3 ) compare ability two synbiotic preparation improve intestinal permeability endotoxemia obese subject ; ( 4 ) ass association gut microbiota test strain biomarkers translocation endotoxemia .</detailed_description>
	<mesh_term>DEFB1 protein , human</mesh_term>
	<criteria>1865 yr , obese ( 30 kg/m2 great ) ( 1 ) prior intestinal resection , ( 2 ) patient history GI diseases except hiatal hernia , GERD , hemorrhoid , ( 3 ) severe renal disease define creatinine twice normal , ( 4 ) markedly abnormal liver function define ALT/AST 4 time normal level elevate bilirubin ( 5 ) antibiotic use within last 12 week prior enrollment , ( 6 ) lean overweight ( BMI &lt; 30 kg/m2 ) , ( 7 ) intolerant aspirin , ( 8 ) regular use aspirin , ( 9 ) excessive alcohol intake ( &gt; 2 drink men , 1 drink woman daily ) , ( 10 ) presence uncontrolled chronic metabolic disease ( cardiovascular disease , insulin require diabetes uncontrolled diabetes , cancer , etc , ( 11 ) plan major change dietary habit follow 6 month , ( 12 ) consumption probiotic , prebiotics synbiotics without appropriate 4 week washout period , ( 13 ) lactose intolerance malabsorption ; ( 14 ) subject young 18 old 65 , ( 15 ) unwillingness consent study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>